Literature DB >> 33322828

Genetic and Clinical Findings in an Ethnically Diverse Cohort with Retinitis Pigmentosa Associated with Pathogenic Variants in CERKL.

Susan M Downes1,2, Tham Nguyen1, Vicky Tai1, Suzanne Broadgate2, Mital Shah1,2, Saoud Al-Khuzaei1,2, Robert E MacLaren1,2, Morag Shanks3, Penny Clouston3, Stephanie Halford2.   

Abstract

Autosomal recessive retinitis pigmentosa is caused by mutations in over 40 genes, one of which is the ceramide kinase-like gene (CERKL). We present a case series of six patients from six unrelated families diagnosed with inherited retinal dystrophies (IRD) and with two variants in CERKL recruited from a multi-ethnic British population. A retrospective review of clinical data in these patients was performed and included colour fundus photography, fundus autofluorescence (AF) imaging, spectral domain-optical coherence tomography (SD-OCT), visual fields and electroretinogram (ERG) assessment where available. Three female and three male patients were included. Age at onset ranged from 7 years old to 45 years, with three presenting in their 20s and two presenting in their 40s. All but one had central visual loss as one of their main presenting symptoms. Four patients had features of retinitis pigmentosa with significant variation in severity and extent of disease, and two patients had no pigment deposition with only macular involvement clinically. Seven variants in CERKL were identified, of which three are novel. The inherited retinopathies associated with the CERKL gene vary in age at presentation and in degree of severity, but generally are characterised by a central visual impairment early on.

Entities:  

Keywords:  CERKL; autosomal recessive (ar); inherited retinal dystrophy (IRD); retinitis pigmentosa (RP); variable phenotype

Year:  2020        PMID: 33322828      PMCID: PMC7763961          DOI: 10.3390/genes11121497

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  58 in total

Review 1.  The molecular basis of human retinal and vitreoretinal diseases.

Authors:  Wolfgang Berger; Barbara Kloeckener-Gruissem; John Neidhardt
Journal:  Prog Retin Eye Res       Date:  2010-03-31       Impact factor: 21.198

2.  Characterization of a ceramide kinase-like protein.

Authors:  Frédéric Bornancin; Diana Mechtcheriakova; Samantha Stora; Christine Graf; Alexander Wlachos; Piroska Dévay; Nicole Urtz; Thomas Baumruker; Andreas Billich
Journal:  Biochim Biophys Acta       Date:  2005-02-21

3.  Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene.

Authors:  Koji M Nishiguchi; Richard G Tearle; Yangfan P Liu; Edwin C Oh; Noriko Miyake; Paola Benaglio; Shyana Harper; Hanna Koskiniemi-Kuendig; Giulia Venturini; Dror Sharon; Robert K Koenekoop; Makoto Nakamura; Mineo Kondo; Shinji Ueno; Tetsuhiro R Yasuma; Jacques S Beckmann; Shiro Ikegawa; Naomichi Matsumoto; Hiroko Terasaki; Eliot L Berson; Nicholas Katsanis; Carlo Rivolta
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

4.  Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencing.

Authors:  Yan Xu; Liping Guan; Tao Shen; Jianguo Zhang; Xueshan Xiao; Hui Jiang; Shiqiang Li; Jianhua Yang; Xiaoyun Jia; Ye Yin; Xiangming Guo; Jun Wang; Qingjiong Zhang
Journal:  Hum Genet       Date:  2014-06-18       Impact factor: 4.132

5.  Clinically Focused Molecular Investigation of 1000 Consecutive Families with Inherited Retinal Disease.

Authors:  Edwin M Stone; Jeaneen L Andorf; S Scott Whitmore; Adam P DeLuca; Joseph C Giacalone; Luan M Streb; Terry A Braun; Robert F Mullins; Todd E Scheetz; Val C Sheffield; Budd A Tucker
Journal:  Ophthalmology       Date:  2017-05-27       Impact factor: 12.079

6.  Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies.

Authors:  Nisha Patel; Mohammed A Aldahmesh; Hisham Alkuraya; Shamsa Anazi; Hadeel Alsharif; Arif O Khan; Asma Sunker; Saleh Al-Mohsen; Emad B Abboud; Sawsan R Nowilaty; Mohammed Alowain; Hamad Al-Zaidan; Bandar Al-Saud; Ali Alasmari; Ghada M H Abdel-Salam; Mohamed Abouelhoda; Firdous M Abdulwahab; Niema Ibrahim; Ewa Naim; Banan Al-Younes; Abeer E AlMostafa; Abdulelah AlIssa; Mais Hashem; Olga Buzovetsky; Yong Xiong; Dorota Monies; Nada Altassan; Ranad Shaheen; Selwa A F Al-Hazzaa; Fowzan S Alkuraya
Journal:  Genet Med       Date:  2015-09-10       Impact factor: 8.822

7.  Application of Whole Exome and Targeted Panel Sequencing in the Clinical Molecular Diagnosis of 319 Chinese Families with Inherited Retinal Dystrophy and Comparison Study.

Authors:  Likun Wang; Jinlu Zhang; Ningning Chen; Lei Wang; Fengsheng Zhang; Zhizhong Ma; Genlin Li; Liping Yang
Journal:  Genes (Basel)       Date:  2018-07-19       Impact factor: 4.096

8.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications.

Authors:  Andy Rimmer; Hang Phan; Iain Mathieson; Zamin Iqbal; Stephen R F Twigg; Andrew O M Wilkie; Gil McVean; Gerton Lunter
Journal:  Nat Genet       Date:  2014-07-13       Impact factor: 38.330

9.  Overexpression of CERKL, a gene responsible for retinitis pigmentosa in humans, protects cells from apoptosis induced by oxidative stress.

Authors:  Miquel Tuson; Alejandro Garanto; Roser Gonzàlez-Duarte; Gemma Marfany
Journal:  Mol Vis       Date:  2009-01-21       Impact factor: 2.367

10.  A New Cerkl Mouse Model Generated by CRISPR-Cas9 Shows Progressive Retinal Degeneration and Altered Morphological and Electrophysiological Phenotype.

Authors:  Elena B Domènech; Rosa Andrés; M José López-Iniesta; Serena Mirra; Rocío García-Arroyo; Santiago Milla; Florentina Sava; Jordi Andilla; Pablo Loza-Álvarez; Pedro de la Villa; Roser Gonzàlez-Duarte; Gemma Marfany
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

View more
  1 in total

Review 1.  Genetic dissection of non-syndromic retinitis pigmentosa.

Authors:  Aarti Bhardwaj; Anshu Yadav; Manoj Yadav; Mukesh Tanwar
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.